Saga Lifesciences Limited — Cefixime Exporter Profile
Indian Pharmaceutical Exporter · #6 for Cefixime · $2.4M export value · DGFT Verified
Saga Lifesciences Limited is the #6 Indian exporter of Cefixime with $2.4M in export value and 47 verified shipments. Saga Lifesciences Limited holds a 1.4% market share in Cefixime exports across 12 countries. The company exports 14 pharmaceutical products worth $7.5M across 8 therapeutic categories.
Saga Lifesciences Limited — Cefixime Export Profile: Buyers & Destinations
Where Does Saga Lifesciences Limited Export Cefixime?
| Country | Value | Shipments | Share |
|---|---|---|---|
| DOMINICAN REPULIC | $177.7K | 16 | 21.8% |
| PHILIPPINES | $132.8K | 3 | 16.3% |
| HONDURAS | $109.9K | 4 | 13.5% |
| BOLIVIA | $91.3K | 4 | 11.2% |
| CHILE | $87.8K | 5 | 10.8% |
| NICARAGUA | $60.3K | 3 | 7.4% |
| DOMINICAN REPUBLIC | $58.0K | 3 | 7.1% |
| HONG KONG | $45.1K | 2 | 5.5% |
| TURKEY | $21.0K | 1 | 2.6% |
| YEMEN | $17.1K | 1 | 2.1% |
Saga Lifesciences Limited exports Cefixime to 13 countries. The largest destination is DOMINICAN REPULIC accounting for 21.8% of Saga Lifesciences Limited's Cefixime shipments, followed by PHILIPPINES (16.3%) and HONDURAS (13.5%). These destinations reflect Saga Lifesciences Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Cefixime from Saga Lifesciences Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TO THE ORDER | HONDURAS | $164.1K | 8 |
| MANAGUA | HONG KONG | $45.1K | 2 |
Saga Lifesciences Limited supplies Cefixime to 2 buyers globally. The largest buyer is TO THE ORDER (HONDURAS). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Cefixime Export Value and How Much Does Saga Lifesciences Limited Contribute?
India exported $61.9M worth of Cefixime through 8,398 shipments from 668 suppliers to 131 countries, serving 1,805 buyers globally. Saga Lifesciences Limited contributes $2.4M to this total, accounting for 1.4% of India's Cefixime exports. Saga Lifesciences Limited ships Cefixime to 13 countries through 2 buyers.
What Is the Average Shipment Value for Saga Lifesciences Limited's Cefixime Exports?
Saga Lifesciences Limited's average Cefixime shipment value is $50.0K per consignment, based on 47 shipments totaling $2.4M. The largest destination is DOMINICAN REPULIC (21.8% of Saga Lifesciences Limited's Cefixime exports).
How Does Saga Lifesciences Limited Compare to Other Indian Cefixime Exporters?
Saga Lifesciences Limited ranks #6 among 668 Indian Cefixime exporters with a 1.4% market share. The top 3 exporters are MICRO LABS LIMITED ($19.1M), AUROBINDO PHARMA LTD ($8.0M), SAKAR HEALTHCARE LIMITED ($4.5M). Saga Lifesciences Limited processed 47 shipments to 12 destination countries.
What Cefixime Formulations Does Saga Lifesciences Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| PHARMACEUTICAL PRODUCTS:CEFILIM CEFIXIME | $132.8K | 3 |
| PHARMACEUTICAL PRODUCTS:SITEX CEFIXIME C | $75.4K | 3 |
| PHARMA. ARTICLE / ODS / PRODUCT / ITEM FOR HUMAN USEHL MEDICINES:CEFIXIME DISPERSIBLE TABLETS 400MG NOCACEF 400DT 952 PAC FOC AS PER INVOICE | $71.8K | 2 |
| PHARMACEUTICAL PRODUCTS FOR HUMAN USE,HARMLESS MEDICINES:Cefixime Capsules 400 mg ZELIS 400 AS PER INVOICE | $58.0K | 3 |
| PHARMACEUTICAL PRODUCTS FOR HUMAN USE,HARMLESS MEDICINES:CEFIXIME CAPSULES SITEXAS PER INVOICE | $38.9K | 1 |
| PHARMACEUTICAL PRODUCTS FOR HUMAN USEHARMLESS MEDICINES:CEFIXIME CAPSULES SITEXEA.CAPS.CONT.CEFIXIME TRIHYDRATE USPNOS | $38.8K | 3 |
| PHARMACEUTICAL PRODUCTS FOR HUMAN USE,HARMLESS MEDICINES:CEFIXIME CAPSULES 400MGZELIS 400 (PACK SIZE : 1X10) | $38.4K | 1 |
| PHARMACEUTICAL ARTICLE / ODS / PRODUCT / ITEM FOR HUMAN USE HARMLESS MEDICINES CEFIXIME FOR ORAL SUSPENSION USP 100 MG PACK SIZE - 100 ML 20 | $32.0K | 1 |
| PHARMACEUTICAL ARTICLE / ODS / PRODUCT / ITEM FOR HUMAN USE HARMLESS MEDICINES CEFIXIME TABLET USP 400 MG PACK SIZE - 3X10 5024 PACKS AS PE | $31.1K | 1 |
| PHARMACEUTICAL PRODUCTS FOR HUMAN USE,HARMLESS MEDICINES:CEFIXIME TABLETS USP 400MG EA.FILM CTD.TAB.CONT.ASPERINV | $31.1K | 1 |
Saga Lifesciences Limited exports 28 distinct Cefixime formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMACEUTICAL PRODUCTS:CEFILIM CEFIXIME with 3 shipments worth $132.8K.
How Does Saga Lifesciences Limited Compare to Nearest Cefixime Exporters?
Exporters ranked immediately above and below #6 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 4 | UNIVENTIS MEDICARE LIMITED | $2.5M | 50 | 1 | $50.0K |
| 15 | SANCE LABORATORIES PRIVATE LIMITED | $2.4M | 82 | 17 | $29.5K |
| 6 | SAGA LIFESCIENCES LIMITED ★ | $2.4M | 47 | 12 | $50.0K |
| 13 | MAAN PHARMACEUTICALS LTD | $950.0K | 19 | 5 | $50.0K |
| 11 | HUMBLE HEALTHCAARE LIMITED | $750.0K | 15 | 7 | $50.0K |
Saga Lifesciences Limited ranks #6 among 668 Indian Cefixime exporters. Average shipment value of $50.0K compared to the market average of $92.6K. The closest competitors by value are UNIVENTIS MEDICARE LIMITED and SANCE LABORATORIES PRIVATE LIMITED.
Which Indian Ports Ship Cefixime Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 924 | 11.0% |
| JNPT | 498 | 5.9% |
| JNPT/ NHAVA SHEVA SEA | 480 | 5.7% |
| SAHAR AIR CARGO ACC (INBOM4) | 449 | 5.3% |
| SAHAR AIR | 412 | 4.9% |
| DELHI AIR CARGO ACC (INDEL4) | 399 | 4.8% |
| DELHI AIR | 366 | 4.4% |
| AHEMDABAD ICD | 226 | 2.7% |
What Other Advanced Antibiotics Products Does Saga Lifesciences Limited Export?
Saga Lifesciences Limited also exports these advanced antibiotics products. Each links to the detailed product page.
About Saga Lifesciences Limited
Saga Lifesciences Limited exports 14 products worth $7.5M. Beyond Cefixime, top products include Vitamin, Tramadol, Itraconazole, Dextromethorphan, Omega. View the complete Saga Lifesciences Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Cefixime — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Cefixime shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Saga Lifesciences Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 47 individual customs records matching Saga Lifesciences Limited exporting Cefixime, covering 28 formulations to 13 countries via 2 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 131+ countries, 1,805+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Cefixime Export Data from Saga Lifesciences Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Saga Lifesciences Limited's Cefixime exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Saga Lifesciences Limited
Full Company Profile →
14 products · $7.5M total trade · 8 categories
Cefixime Stats
Company Overview
Top Products by Saga Lifesciences Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Saga Lifesciences Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Cefixime. For current shipment-level data, contact TransData Nexus.